Beate Kiese

7.4k total citations · 1 hit paper
10 papers, 2.2k citations indexed

About

Beate Kiese is a scholar working on Pharmacology, Pathology and Forensic Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Beate Kiese has authored 10 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmacology, 2 papers in Pathology and Forensic Medicine and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Beate Kiese's work include Neuroscience and Neuropharmacology Research (2 papers), Gastrointestinal Tumor Research and Treatment (2 papers) and Bone health and osteoporosis research (2 papers). Beate Kiese is often cited by papers focused on Neuroscience and Neuropharmacology Research (2 papers), Gastrointestinal Tumor Research and Treatment (2 papers) and Bone health and osteoporosis research (2 papers). Beate Kiese collaborates with scholars based in Switzerland, United States and France. Beate Kiese's co-authors include Margaret von Mehren, Sandra Silberman, Peter Roberts‎, Brian Druker, Christopher D.�M. Fletcher, Heikki Joensuu, Samuel Singer, George D. Demetri, Annick D. Van den Abbeele and Christopher L. Corless and has published in prestigious journals such as Science, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Beate Kiese

10 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor

2003 1.7k citations Michael C. Heinrich, Christopher L. Corless et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Beate Kiese Switzerland	8	1.2k	1.1k	581	379	375	10	2.2k
Suash Sharma United States	21	65 0.1×	307 0.3×	200 0.3×	245 0.6×	622 1.7×	68	1.8k
Ying Xiong China	22	170 0.1×	331 0.3×	322 0.6×	409 1.1×	529 1.4×	92	1.5k
Robert Bränström Sweden	20	112 0.1×	186 0.2×	553 1.0×	177 0.5×	602 1.6×	69	1.5k
Mika Leinonen United States	24	86 0.1×	248 0.2×	96 0.2×	410 1.1×	716 1.9×	43	2.2k
Kshama Mehta United States	19	65 0.1×	213 0.2×	379 0.7×	201 0.5×	925 2.5×	22	1.8k
Shau-Hsuan Li Taiwan	21	54 0.0×	288 0.3×	136 0.2×	476 1.3×	573 1.5×	35	1.3k
Tatsuo Kimura Japan	22	40 0.0×	524 0.5×	147 0.3×	508 1.3×	398 1.1×	108	1.4k
Jing‐Ping Lin United States	21	23 0.0×	327 0.3×	211 0.4×	303 0.8×	788 2.1×	52	2.1k
Ewa Matyja Poland	24	36 0.0×	184 0.2×	284 0.5×	135 0.4×	614 1.6×	127	1.9k
Le Zhang China	18	38 0.0×	170 0.2×	200 0.3×	225 0.6×	390 1.0×	53	1.0k

Countries citing papers authored by Beate Kiese

Since Specialization

Citations

This map shows the geographic impact of Beate Kiese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beate Kiese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beate Kiese more than expected).

Fields of papers citing papers by Beate Kiese

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beate Kiese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beate Kiese. The network helps show where Beate Kiese may publish in the future.

Co-authorship network of co-authors of Beate Kiese

This figure shows the co-authorship network connecting the top 25 collaborators of Beate Kiese. A scholar is included among the top collaborators of Beate Kiese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beate Kiese. Beate Kiese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Heinrich, Michael C., Christopher L. Corless, George D. Demetri, et al.. (2023). Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor. Journal of Clinical Oncology. 41(31). 4829–4836. 8 indexed citations

2.

Seefried, Lothar, Christine Hofmann, Erdmute Kunstmann, et al.. (2017). Efficacy of anti-sclerostin monoclonal antibody BPS804 in adult patients with hypophosphatasia. Journal of Clinical Investigation. 127(6). 2148–2158. 57 indexed citations

3.

Mindeholm, Linda, Aino Launonen, Beate Kiese, et al.. (2012). The single dose pharmacokinetic profile of a novel oral human parathyroid hormone formulation in healthy postmenopausal women. Bone. 50(4). 965–973. 37 indexed citations

4.

Rupprecht, Rainer, Gerhard Rammes, Daniela Eser, et al.. (2009). Translocator Protein (18 kD) as Target for Anxiolytics Without Benzodiazepine-Like Side Effects. Science. 325(5939). 490–493. 272 indexed citations

5.

Gardin, Anne, Klaus Kucher, Beate Kiese, & Silke Appel‐Dingemanse. (2009). Cannabinoid Receptor Agonist 13, a Novel Cannabinoid Agonist: First in Human Pharmacokinetics and Safety. Drug Metabolism and Disposition. 37(4). 827–833. 26 indexed citations

6.

Lefèvre, Gilbert, F. Pommier, G Sędek, et al.. (2008). Pharmacokinetics and Bioavailability of the Novel Rivastigmine Transdermal Patch Versus Rivastigmine Oral Solution in Healthy Elderly Subjects. The Journal of Clinical Pharmacology. 48(2). 246–252. 35 indexed citations

7.

Lefèvre, Gilbert, G Sędek, Marc Saltzman, et al.. (2007). Pharmacokinetics of a Rivastigmine Transdermal Patch Formulation in Healthy Volunteers: Relative Effects of Body Site Application. The Journal of Clinical Pharmacology. 47(4). 471–478. 50 indexed citations

8.

Heinrich, Michael C., Christopher L. Corless, George D. Demetri, et al.. (2003). Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor. Journal of Clinical Oncology. 21(23). 4342–4349. 1719 indexed citations breakdown →

9.

Brouwer, Rolf E., Koos Zwinderman, W. R. Bezwoda, et al.. (1999). Phase III efficacy study of interleukin‐3 after autologous bone marrow transplantation in patients with malignant lymphoma. British Journal of Haematology. 106(3). 730–736. 2 indexed citations

10.

Hofstra, L.S., Gunnar B. Kristensen, P.H.B. Willemse, et al.. (1998). Randomized trial of recombinant human interleukin-3 versus placebo in prevention of bone marrow depression during first-line chemotherapy for ovarian carcinoma.. Journal of Clinical Oncology. 16(10). 3335–3344. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact